Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 550

1.
2.

Individual- and neighborhood-level factors associated with nonprescription counseling in pharmacies participating in the New York State Expanded Syringe Access Program.

Rivera AV, Blaney S, Crawford ND, White K, Stern RJ, Amesty S, Fuller C.

J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):580-7. doi: 10.1331/JAPhA.2010.09202.

3.

Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC.

J Urban Health. 2009 Nov;86(6):929-45. doi: 10.1007/s11524-009-9399-7.

4.

Racial and ethnic disparities in influenza vaccinations among community pharmacy patients and non-community pharmacy respondents.

Wang J, Munshi KD, Hong SH.

Res Social Adm Pharm. 2014 Jan-Feb;10(1):126-40. doi: 10.1016/j.sapharm.2013.04.011.

5.

Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.

Tesoriero JM, Battles HB, Klein SJ, Kaufman E, Birkhead GS.

J Am Pharm Assoc (2003). 2009 May-Jun;49(3):407-16. doi: 10.1331/JAPhA.2009.07127.

PMID:
19443321
6.

Pharmacy staff characteristics associated with support for pharmacy-based HIV testing.

Amesty S, Blaney S, Crawford ND, Rivera AV, Fuller C.

J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):472-9, 1-9. doi: 10.1331/JAPhA.2012.10194.

7.

Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users.

Crawford ND, Amesty S, Rivera AV, Harripersaud K, Turner A, Fuller CM.

Health Educ Behav. 2014 Aug;41(4):397-405. doi: 10.1177/1090198114529131.

PMID:
24722219
8.

"We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics.

Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL.

N Engl J Med. 2000 Apr 6;342(14):1023-6.

9.

What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.

Klein SJ, Harris-Valente K, Candelas AR, Radigan M, Narcisse-Pean M, Tesoriero JM, Birkhead GS.

J Urban Health. 2001 Dec;78(4):679-89.

10.

Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002).

Finkelstein R, Tiger R, Greenwald R, Mukherjee R.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S83-7.

PMID:
12489622
11.

More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.

Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S62-7.

PMID:
12489618
12.
13.

Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.

Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, Vlahov D.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S77-82.

PMID:
12489621
14.

The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.

Puspitasari HP, Aslani P, Krass I.

Int J Clin Pharm. 2015 Oct;37(5):834-43. doi: 10.1007/s11096-015-0127-y.

PMID:
25964140
15.

Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.

Atkins K, van Hoek AJ, Watson C, Baguelin M, Choga L, Patel A, Raj T, Jit M, Griffiths U.

BMJ Open. 2016 Feb 16;6(2):e009739. doi: 10.1136/bmjopen-2015-009739.

16.

Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.

Liao Y, Bang D, Cosgrove S, Dulin R, Harris Z, Taylor A, White S, Yatabe G, Liburd L, Giles W; Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion.; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2011 May 20;60(6):1-44.

17.

Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.

Fuller CM, Galea S, Blaney S, Ompad DC, Deren S, Des Jarlais D, Vlahov D.

Ethn Dis. 2004 Autumn;14(4):589-96.

PMID:
15724781
18.

Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.

Rosenthal J, Rodewald L, McCauley M, Berman S, Irigoyen M, Sawyer M, Yusuf H, Davis R, Kalton G.

Pediatrics. 2004 Apr;113(4):e296-302.

PMID:
15060256
19.

Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.

Wibowo Y, Parsons R, Sunderland B, Hughes J.

Int J Clin Pharm. 2015 Oct;37(5):873-82. doi: 10.1007/s11096-015-0135-y.

PMID:
25986291
20.

Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience.

Goad JA, Taitel MS, Fensterheim LE, Cannon AE.

Ann Fam Med. 2013 Sep-Oct;11(5):429-36. doi: 10.1370/afm.1542.

Supplemental Content

Support Center